UroGen Pharma Ltd.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $21.4m $37.0m $101.3m $49.7m $52.9m $44.4m $55.4m $95.0m $172.0m $110.7m
Prepaid Expense and Other Assets, Current $396k $958k $672k $1.0m $3.4m $7.5m $11.1m $10.3m $8.8m $14.7m
Cash, Cash Equivalents, and Short-term Investments $141.5m $241.7m $120.5m
Short-term Investments $36.0m $56.2m $110.7m $49.3m
Inventory, Net $105k $316k $2.0m $4.8m $4.3m $5.7m $9.2m $16.5m
Assets, Current $22.0m $74.5m $102.2m $148.6m $115.6m $114.4m $128.9m $169.2m $276.1m $186.0m
Property, Plant and Equipment, Net $741k $805k $948k $977k $2.0m $2.0m $1.3m $689k $655k $637k
Operating Lease, Right-of-Use Asset $3.7m $2.2m $1.2m $2.5m $1.7m $849k $3.1m
Other Assets, Noncurrent $250k $244k $317k $264k $66k $1.3m $2.7m $2.0m $589k $5.2m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $83k $7.0m $11.7m $12.7m $15.4m $20.3m $33.1m
Assets $23.1m $75.5m $103.6m $202.4m $122.0m $119.7m $135.6m $178.3m $285.7m $200.5m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $1.6m $1.2m $785k $481k
Accounts Payable, Current $4.3m $4.7m $3.3m $5.8m $5.5m $6.5m $10.9m $12.1m
Operating Lease, Liability, Noncurrent $2.6m $1.5m $398k $1.6m $844k $58k $2.6m
Deferred Revenue, Current $650k
Long-term Debt, Excluding Current Maturities $97.5m $98.6m $121.7m $122.2m
Liabilities, Current $3.1m $7.0m $13.5m $19.5m $21.4m $22.4m $23.9m $31.2m $45.9m $46.4m
Liabilities $6.7m $7.0m $13.5m $22.1m $25.6m $111.3m $225.0m $243.5m $294.5m $305.9m
Stockholders’ equity:
Common Stock, Value, Issued $6k $37k $44k $57k $60k $61k $63k $89k $115k $133k
Additional Paid in Capital $43.5m $115.7m $212.9m
Retained Earnings (Accumulated Deficit) ($27.2m) ($47.2m) ($122.9m) ($228.0m) ($356.5m) ($467.3m) ($577.1m) ($679.3m) ($806.2m) ($959.7m)
Accumulated Other Comprehensive Income (Loss), Net of Tax $276k $271k ($25k) ($107k) $12k $56k $19k
Additional Paid in Capital, Common Stock $408.0m $452.5m $475.7m $487.8m $614.0m $797.2m $854.1m
Stockholders' Equity Attributable to Parent $16.3m $68.5m $90.1m $180.3m $96.4m $8.4m ($89.4m) ($65.2m) ($8.8m) ($105.5m)
Liabilities and Equity $23.1m $75.5m $103.6m $202.4m $122.0m $119.7m $135.6m $178.3m $285.7m $200.5m